21 May 2013
Keywords: hematide, corrects, anemia, ckd, patients, drugmaker, affymax
Article | 30 April 2007
US drugmaker Affymax says that the results to date from two separate Phase II trials of Hematide in dialysis and ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 April 2007
23 April 2007
21 May 2007
© 2013 thepharmaletter.com